Unexplained Outpatient Electrolyte Abnormality May Signal Eating Disorder
WEDNESDAY, Nov. 9, 2022 (HealthDay News) -- Nearly one in five individuals diagnosed with an eating disorder had a preceding outpatient electrolyte abnormality, according to a study published online Nov. 8 in JAMA Network Open.
Gregory L. Hundemer, M.D., from Ottawa Hospital-Riverside Campus in Canada, and colleagues assessed whether outpatient electrolyte abnormalities are associated with the future diagnosis of an eating disorder. The analysis included provincial administrative health data for residents of Ontario (aged 13 years and older) from 2008 to 2020, with incident eating disorder cases (6,970 patients) matched by age and sex to controls (27,878 residents).
The researchers found that 18.4 percent of individuals with an eating disorder had a preceding electrolyte abnormality versus 7.5 percent of individuals without an eating disorder (adjusted odds ratio [aOR], 2.12). A median (interquartile range) time of 386 days was observed from the earliest electrolyte abnormality to eating disorder diagnosis. A higher risk for an eating disorder was associated with hypokalemia (aOR, 1.98), hyperkalemia (aOR, 1.97), hyponatremia (aOR, 5.26), hypernatremia (aOR, 3.09), hypophosphatemia (aOR, 2.83), and metabolic alkalosis (aOR, 2.60).
"These results suggest that otherwise unexplained outpatient electrolyte abnormalities may serve to identify individuals who should be screened for an underlying eating disorder," the authors write.
One author disclosed financial ties to the pharmaceutical industry.
Related Posts
Cardiometabolic Diseases Accelerate Cognitive Decline, Dementia
WEDNESDAY, June 22, 2022 (HealthDay News) -- Cardiometabolic disease (CMD)...
Could Obesity Blunt the Response to the COVID Vaccine?
FRIDAY, May 6, 2022 (HealthDay News) -- Obesity can complicate the course of...
Biden to Sign Executive Order Protecting Women Traveling for Abortion
WEDNESDAY, Aug. 3, 2022 (HealthDay News) -- President Joe Biden was poised to...
NIH Launches Clinical Trial of Epstein-Barr Virus Vaccine
TUESDAY, May 10, 2022 (HealthDay News) -- The U.S. National Institutes of Health...